The FASEB Journal, Vol 4, 3124-3130, Copyright © 1990 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene

HC Schroder, D Ugarkovic, H Merz, Y Kuchino, T Okamoto and WE Muller
Institut fur Physiologische Chemie, Universitat, Mainz, West Germany.

An expression vector (pU3R-III/2-5AS) of human 2',5'-oligoadenylate (2- 5A) synthetase was constructed in which a cDNA encoding an active form of the enzyme was located 3' to a 3'-long terminal repeat (LTR) of human immunodeficiency virus type 1 (HIV-1). The LTR-directed expression of this hybrid DNA could be activated in trans by the HIV tat gene product. This vector was used for transfection of HeLa-T4+ cells, which are permissive to HIV infection, as well as of normal HeLa cells. HIV replication after infection of the CD4-receptor-bearing HeLa- T4+ cells with HIV-1 was found to be strongly reduced when drug- selected cells cotransfected with pU3R-III/2-5AS and a hygromycin B resistance gene containing plasmid were used. In nontransfected cultures or after transfection with the selectable marker plasmid only, about 60% p17- and p24-positive cells were found 5 days after infection. However, after stable transfection with pU3R-III/2-5AS the number of positive cells was decreased to about 2%. The reverse transcriptase (RT) activity, as a measure for virus production, was markedly decreased in the culture fluids of pU3R-III/2-5AS transfected cells compared with the mock-transfected controls. In parallel experiments it was established that Tat-mediated trans-activation of HIV-1 LTR-directed 2-5A synthetase expression resulted in a great increase in both 2-5A synthetase mRNA level and activity as well as in cellular 2-5A content. Similar results were found in HeLa-T4+ cells and in HeLa cells (without CD4 receptor) cotransfected with pU3R-III/2-5AS and a tat gene containing plasmid or after introduction of purified Tat protein into the pU3R-III/2-5AS transfected cells by using a modified scrape loading procedure. These results indicate that HIV-trans- activated 2-5A synthetase can selectively inhibit HIV replication in vitro, and might be a promising gene therapeutical approach.

This article has been cited by other articles:

				K. Paemeleire, P. E. M. Martin, S. L. Coleman, K. E. Fogarty, W. A. Carrington, L. Leybaert, R. A. Tuft, W. H. Evans, and M. J. Sanderson Intercellular Calcium Waves in HeLa Cells Expressing GFP-labeled Connexin 43, 32, or 26 Mol. Biol. Cell, May 1, 2000; 11(5): 1815 - 1827. [Abstract] [Full Text]

				C. Martinand, C. Montavon, T. Salehzada, M. Silhol, B. Lebleu, and C. Bisbal RNase L Inhibitor Is Induced during Human Immunodeficiency Virus Type 1 Infection and Down Regulates the 2-5A/RNase L Pathway in Human T Cells J. Virol., January 1, 1999; 73(1): 290 - 296. [Abstract] [Full Text] [PDF]

				R. K. Maitra and R. H. Silverman Regulation of Human Immunodeficiency Virus Replication by 2',5'-Oligoadenylate-Dependent RNase L J. Virol., February 1, 1998; 72(2): 1146 - 1152. [Abstract] [Full Text] [PDF]